Consumer Health and Well-Being
Highlight Performance
2025 Target
Domestic beverage products contain less than 6% sugar or are sugar-free
2025 Target
At least 50% of health and confectionery products contain no added sugar
Current health issues, particularly non-communicable diseases (NCDs), continue to intensify, leading to an increasing number of premature deaths. According to the World Health Organization (WHO), NCDs cause at least 43 million deaths each year, accounting for approximately 75% of all deaths globally based on 2021 data. Of these, 18 million people die before the age of 70, with more than 82% of such premature deaths occurring in low- and middle-income countries.
One of the key contributing factors is unhealthy consumption behavior, including the high intake of sugar, fat, or sodium in food and beverages. As a result, consumers are increasingly seeking products that support better health, while still expecting nutritional value, taste profiles similar to existing products, and affordable prices.
At the same time, the energy drink and functional drink industries continue to attract growing interest, as consumers are looking for beverages that do more than simply quench thirst. They expect products that provide additional health benefits, such as energy support, digestive support, or immune system support. Convenience, product accessibility, and affordability are all factors that help drive the growth of this market in line with the behavior of health-conscious consumers.
In response, the Company places importance on developing new products that respond to the needs of consumers in the era of the modern diet. The Company aims to increase the proportion of products containing beneficial nutrients, with reduced or no added sugar, while maintaining taste and affordability. This approach supports a balance between health and long-term consumption experience.
Osotspa has identified the promotion of consumer health, nutrition, and well-being as a key objective in product development across its beverage portfolio. This commitment extends throughout the value chain, from research and development and raw material sourcing to manufacturing and consumer communication. The Company is committed to developing high-quality and safe products while delivering nutritional value across both energy drink and functional beverage categories. The Company continues to reformulate its products to contain less than 6% sugar and enhance their nutritional content to address the needs of consumers seeking specific health benefits, while taking into consideration potential adverse impacts on vulnerable consumer groups. The Company’s sugar reduction efforts are aligned with World Health Organization (WHO) recommendations on reducing sugar intake to help prevent non-communicable diseases (NCDs) and promote long-term consumer health and well-being.
To effectively advance its health and nutrition strategy, the Company has established clear roles and responsibilities. The Board of Directors oversees the overall health and nutrition strategy to ensure alignment with the Company’s sustainability vision. Senior management is responsible for setting strategic direction and policies, allocating necessary resources, and monitoring performance. Cross-functional teams, including R&D, Marketing, Product Quality, and Sustainability, work together to develop, review, and validate nutrition- and health-related communications to ensure scientific accuracy and compliance with applicable national and international laws and standards. This management approach enables the Company to systematically manage health- and nutrition-related risks and opportunities while creating sustainable shared value for consumers and society.
Osotspa continues to reduce sugar content in its products through product reformulation and the development of healthier alternatives, particularly products that address the needs of vulnerable consumer groups and consumers seeking specific health benefits. The Company also focuses on expanding its functional beverage portfolio to better address consumers’ nutritional needs. Going forward, the Company will expand its range of reduced-sugar beverages in line with international nutritional criteria and Thailand’s Healthier Choice guidelines, while continuing to research and develop a broader range of low-sugar and sugar-free products. The Company will also promote consumer communication to support consumers in choosing beverages that are appropriate for their individual health needs.
Osotspa Health and Nutrition Policy
Osotspa is committed to enhancing consumer health and well-being through the Company’s Innovation Center by developing and improving products to provide appropriate nutritional value for diverse consumer groups. The Company also promotes transparent nutrition information and leverages the strength of its brands to encourage healthier consumption behaviors. The key principles of the Health and Nutrition Policy are as follows:
Nutritious, Delicious, Forward-Looking
Responsible
Apply the Osotspa Nutritional Criteria as a standard for product development, including:
- Sugar: ≤ 5 g/100 ml
- Energy: ≤ 40 kcal/100 ml (or ≤ 20/10 kcal, depending on the formulation)
The Company regularly reviews its Nutritional Criteria in consultation with the Health & Nutrition Advisory Panel to maintain alignment with recommendations from the World Health Organization (WHO), public health authorities, and Healthier Choice standards.
Accessible and Affordable
OSP Nutrition Advisory Panel
Osotspa has established a Health & Nutrition Advisory Panel to support the implementation of the Company’s Health and Nutrition Policy. The Panel has the following roles and responsibilities:
Provide Advice on Osotspa’s Health and Nutrition Policy
- Provide advice on Osotspa’s Health and Nutrition Policy.
- Provide recommendations on health and nutrition policies, communications, and policy-related initiatives, including recommendations for policy improvements in alignment with national and international health and nutrition standards and recognized practices.
- Document all recommendations in meeting minutes or reports, together with supporting rationale, and submit them to the Health and Nutrition Team and the Sustainable Development Working Team.
- Refer recommendations involving changes to Company policies or external commitments to senior management for consideration.
Provide Relevant and Up-to-Date Information
Provide up-to-date academic and technical information on health and nutrition, technology, global and local markets, consumer trends, and emerging laws and regulations to support the Health and Nutrition Hub and relevant operational teams.
Provide Health and Nutrition Guidance to Research and Development (R&D)
Support product innovation and formulation development by providing health and nutrition guidance through the Health and Nutrition Hub to ensure alignment with the Company’s health and nutrition objectives.
Promote Health and Nutrition Awareness Internally and Externally
Support initiatives and communications that enhance health and nutrition knowledge and awareness through Company channels, including the sustainability website and other publicly available information channels.
Collaborate and Exchange Knowledge with External Stakeholders
Engage and collaborate with businesses, academics, and government agencies to exchange health- and nutrition-related knowledge in areas of mutual benefit. Document all formal external collaborations and meetings, including details of information shared and received. Ensure that any information related to Osotspa is handled in accordance with the Company’s Code of Conduct and Information Security Policy. Obtain prior approval from the Chair of the Health & Nutrition Advisory Panel before initiating discussions on new external collaborations that may affect the Company’s reputation or require significant resources, to avoid creating inappropriate external expectations.
Management and Awareness of Potential Adverse Product Impacts on Consumers and Vulnerable Groups
Osotspa recognizes the importance of managing potential adverse impacts of its products on all consumers, particularly vulnerable groups such as children, older persons, individuals with medical conditions or specific health needs, and pregnant women. The Company therefore oversees product safety at every stage, from product development and manufacturing to quality assessment, consumer communication, and distribution, to ensure that its products are safe, meet applicable standards, and fully comply with relevant laws and regulations.
The Company aims to enable consumers to make informed and appropriate choices by providing sufficient and transparent information, including nutritional information, nutrient content, appropriate consumption guidance, and warnings for vulnerable groups. Serving sizes and on-pack communications are carefully considered to help reduce the risk of overconsumption and promote mindful and safe consumption across different age groups. For example, M-150 energy drinks clearly display an on-pack warning stating: “Do not consume more than two cans per day, as excessive consumption may cause heart palpitations and insomnia. Children and pregnant women should not consume this product, and individuals with underlying medical conditions should consult a physician before consumption.” Consumer hotline contact information is also provided, enabling consumers to conveniently make inquiries or raise concerns.
Product Quality and Safety
Osotspa is committed to delivering high-quality and safe products that meet consumer needs. The Company’s products have been recognized for their quality and standards for more than a century, supported by the collective efforts of employees throughout the production process. The Company places importance on delivering quality products in optimal condition and on time, both domestically and internationally, to enhance market opportunities and brand recognition while facilitating effective collaboration with customers and business partners.
In line with its commitment to operational excellence, the Company has established a standardized operating framework across all manufacturing facilities within the Group. The framework incorporates quality and safety requirements in accordance with national and international food standards and applies quality controls throughout the product lifecycle, from design and manufacturing to distribution. The Company utilizes precise production control technologies, conducts hazard analyses and identifies critical control points, and has mechanisms in place to monitor and assess potential risks effectively.
In addition, Osotspa applies the criteria of Thailand’s Healthier Choice Logo in the reformulation and development of its beverage products. Examples of products that have received the Healthier Choice Logo include Calpis Soda Mango Parfait, Okinawa Pineapple, and Kyoho Grape flavors, as well as Calpis Lacto Passion Fruit and Apple Tea flavors.
| 2021 | 2022 | 2023 | 2024* | 2025 | |
|---|---|---|---|---|---|
| Revenue from Products with the Healthier Choice Logo (THB) | 3,877,000,000 | 3,852,000,000 | 2,628,000,000 | 1,775,000,000 | 369,481,343 |
| Total Revenue from Food and Beverage Products (THB) | 22,708,622,000 | 22,020,057,000 | 21,129,597,000 | 22,153,901,000 | 21,422.744,111 |
| Percentage of Revenue from Products with the Healthier Choice Logo (%) | 17.07% | 17.49% | 12.43% | 8.01% | 1.72% |
Access to Medicines and Responsible Pharmaceutical Practices
Access to medicines and responsible pharmaceutical practices form part of Osotspa’s Product Quality, Food Safety and Halal Policy. The Company registers pharmaceutical products and prepares registration dossiers in compliance with the requirements of the Thai Food and Drug Administration (Thai FDA), Ministry of Public Health, in accordance with the ASEAN Common Technical Dossier (ACTD), a common framework for the preparation of pharmaceutical registration dossiers across ASEAN Member States. This approach supports consistent registration standards in Thailand and across the ASEAN region, contributing to equitable access to quality, safe, and effective medicines. The Company operates according to the following principles:
- Responsible Advertising and Marketing – Conduct pharmaceutical advertising and marketing in compliance with applicable laws and Thai FDA regulations under the Drug Act B.E. 2510 (1967), as amended. All communications and advertisements relating to the Company’s pharmaceutical products must receive approval from the Thai FDA prior to publication to ensure that information is accurate, transparent, and not misleading to consumers.
- Industry Collaboration and Knowledge Sharing – Maintain membership in the Pharmaceutical Industry Club of the Federation of Thai Industries, which promotes the development and capabilities of Thailand’s pharmaceutical industry to strengthen self-reliance and enhance competitiveness in line with international standards. Through this collaboration, the Company receives updates on regulatory developments, pharmaceutical development guidelines, and knowledge from government agencies, which are used to improve manufacturing processes and pharmaceutical product development in compliance with applicable laws and Thai FDA requirements, helping to ensure the safety, quality, and efficacy of its pharmaceutical products.
- Responsible Marketing Practices and Personnel Development – Prepare pharmaceutical labels and package inserts in accordance with the information contained in product registrations approved by the Thai FDA and verify their accuracy prior to distribution to ensure that consumers receive complete and appropriate information for safe use. Ensure that all advertising materials and marketing communications relating to pharmaceutical products receive Thai FDA approval prior to publication. Appoint responsible pharmacists to oversee pharmaceutical manufacturing, quality control, and distribution in compliance with applicable laws and Thai FDA requirements. These pharmacists are required to complete training in accordance with the requirements of the Pharmacy Council of Thailand to ensure that they have the appropriate knowledge, understanding, and readiness to perform their duties in compliance with the Drug Act B.E. 2510 (1967) and professional ethical standards.